Which test is indicated for cervical cancer screening?

The PAP Screen is the correct choice for cervical cancer screening because it is specifically designed to detect abnormal cells in the cervix that may indicate the presence of cervical cancer or conditions that could lead to cancer. This test involves collecting cells from the cervix, which are then examined under a microscope for any signs of malignancy or precancerous changes. Regular screening with the PAP test is an essential part of preventive health care for individuals with a cervix, as it has been shown to significantly reduce the incidence and mortality of cervical cancer through early detection and treatment.

The other tests listed are not indicated for cervical cancer screening. The PSA Diagnostic is primarily used for prostate cancer screening in males, while the AFP Tumor Marker is associated with liver cancer and certain testicular cancers. CA125 is a tumor marker often used to monitor ovarian cancer rather than to screen for cervical cancer. This context highlights the specific applications of each test, clarifying why the PAP Screen is the appropriate choice for cervical cancer screening.